SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 02, 16:00
657.80
22.4 (3.53%)
VOLUME 159,529
LIVE
NSE
Sep 02, 15:59
657.60
21.15 (3.32%)
VOLUME 1,599,133

Stock Advice on Ranbaxy Laboratories

Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Buy Ranbaxy Laboratories, says Manas Jaiswal 

2.35 pm | 02 Sep 2014 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com recommends buying Ranbaxy Laboratories as the stock may touch Rs 680 in next two to three trading sessions....

Hold Ranbaxy Lab; target Rs 750-770: Akshata Deshmukh 

4.44 pm | 22 Aug 2014 |  Source: CNBC-TV18

Akshata Deshmukh, Chief Strategist-Trading at Networth Stock Broking is of the view that one may hold Ranbaxy Laboratories with a target of Rs 750-770...

Checkout: What is PLilladher recommending in pharma space 

3.36 pm | 22 Aug 2014 |  Source: CNBC-TV18

Surajit Pal picks Glenmark as his top pharma bet among midcaps....

Stay with Ranbaxy Laboratories: Hemen Kapadia 

4.49 pm | 21 Aug 2014 |  Source: CNBC-TV18

Hemen Kapadia of KR Choksey Securities is of the view that one may hold Ranbaxy Laboratories....

Hold Ranbaxy Laboratories, says Ashu Madan 

3.36 pm | 21 Aug 2014 |  Source: CNBC-TV18

Ashu Madan of Religare Securities is of the view that one may hold Ranbaxy Laboratories....

Add Ranbaxy Laboratories, target Rs 650-660: Hemant Thukral 

11.17 am | 21 Aug 2014 |  Source: CNBC-TV18

Hemant Thukral of Aditya Birla Money recommends adding Ranbaxy Laboratories as the stock may head towards Rs 650-660....

Expect upmove in Ranbaxy: Sudarshan Sukhani 

1.08 pm | 31 Jul 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may see very large move on the upside in Ranbaxy Laboratories....

Ranbaxy Laboratories may test Rs 610-615: Hemant Thukral 

12.14 pm | 28 Jul 2014 |  Source: CNBC-TV18

Hemant Thukral of Aditya Birla Money is of the view that Ranbaxy Laboratories may test Rs 610-615 and feels that one should exit around Rs 600-610....

Defensives are back: Aditya Birla Money 

11.02 am | 28 Jul 2014 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Hemant Thukral of Aditya Birla Money shares his outlook on stock specific bets and where the market is headed hereon....

Super Six stock ideas to liven up your trade 

8.19 am | 28 Jul 2014 |  Source: CNBC-TV18

Kunal Saraogi of Equityrush advises selling Tata Power Company with a target of Rs 96 and State Bank of India (SBI) with a target of Rs 2400....

12
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.